Chelation Therapy News and Research

RSS
Chelation therapy is the administration of chelating agents to remove heavy metals from the body.
Nano therapy reverses deadliest effects of chronic kidney disease in animal model

Nano therapy reverses deadliest effects of chronic kidney disease in animal model

People who use indoor firing ranges at risk of lead poisoning

People who use indoor firing ranges at risk of lead poisoning

Brazilian researchers propose new way for treating thalassemia major

Brazilian researchers propose new way for treating thalassemia major

Authors examine potential reasons for the persistence of FC, other autism fads

Authors examine potential reasons for the persistence of FC, other autism fads

FDA accepts Sangamo BioSciences' IND for SB-BCLmR-HSPC genome editing approach

FDA accepts Sangamo BioSciences' IND for SB-BCLmR-HSPC genome editing approach

Agios begins AG-348 Phase 1 study to treat PK deficiency

Agios begins AG-348 Phase 1 study to treat PK deficiency

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Chelation therapy with drug disodium EDTA reduces risk of heart attack

Chelation therapy with drug disodium EDTA reduces risk of heart attack

EDTA chelation, high-dose vitamins/minerals may provide additional benefit for MI patients

EDTA chelation, high-dose vitamins/minerals may provide additional benefit for MI patients

Acceleron commences ACE-536 phase 2 study in beta-thalassemia

Acceleron commences ACE-536 phase 2 study in beta-thalassemia

Study: Controversial treatment for autism spectrum disorder may be harmful

Study: Controversial treatment for autism spectrum disorder may be harmful

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

First Edition: January 23, 2012

First Edition: January 23, 2012

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

ApoPharma receives FDA approval for Ferriprox to treat transfusional iron overload

ApoPharma receives FDA approval for Ferriprox to treat transfusional iron overload

ODAC recommends ApoPharma's Ferriprox for FDA approval to treat transfusional iron overload

ODAC recommends ApoPharma's Ferriprox for FDA approval to treat transfusional iron overload

Study: U.S. health care workers often use complementary and alternative medicine

Study: U.S. health care workers often use complementary and alternative medicine

FDA clears Resonance Health's MRI-Q System for cardiac T2* iron assessment

FDA clears Resonance Health's MRI-Q System for cardiac T2* iron assessment

EGT transfers clinical grade lentiviral vector to MSKCC

EGT transfers clinical grade lentiviral vector to MSKCC